Evidence map›Paper›PMID 41111845›Full record

ArticleCureus2025

Cannabinoid Hyperemesis Syndrome: A Rare Cause of Severe Abdominal Pain and Hyperlactataemia.

Ahmad Elbaghdady, Abdelnasser Ahmed, Ahmed Elmahdy

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ahmad ElbaghdadyAcute Medicine, King's Mill Hospital/Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, GBR.
Abdelnasser AhmedInternal Medicine, King's Mill Hospital/Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, GBR.
Ahmed ElmahdyInternal Medicine, King's Mill Hospital/Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabinoid hyperemesis syndrome (CHS) is an emerging disorder in chronic cannabis users, characterized by recurrent nausea, vomiting, severe abdominal pain, and compulsive hot bathing. We report a case of CHS complicated by profound lactic acidosis (lactate 6.1 mmol/L), highlighting this metabolic derangement as a secondary effect of severe dehydration and physiological stress from intractable vomiting and pain. Our case underscores the importance of early recognition of CHS even when abdominal pain predominates, aggressive fluid resuscitation, and targeted therapies including haloperidol and capsaicin. We also review current evidence on CHS pathophysiology, diagnostic criteria, and management strategies, alongside the increasing prevalence in correlation with rising cannabis use in the UK.

Indexed as

abdominal paincannabinoid hyperemesis syndromecannabiscapsaicincase reportcyclic vomitinghaloperidolhot bathinglactic acidosis

Identifiers

PMID41111845
PMCPMC12530165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.